FDA's post-approval studies continue to suffer delays and setbacks.
Cassandra
C
Willyard
D002986:Clinical Trials as Topic; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004345:Drug Industry; D006291:Health Policy; D006801:Humans; D008272:Mafenide / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D008272:Mafenide